Although inhibition of p16 transcription via promoter DNA methylation is a relatively common mechanism used by human tumors to prevent p16 accumulation [75], we found that Δ3C virus-infected lymphomas continued to express high-level p16, and thus must have developed other mechanisms to circumvent its growth inhibitory effect. The gene discussed is CDKN2A; the disease is lymphoma.